ArchiMed to take Esperion Therapeutics private for $1.1bn

The transaction is expected to close in the third quarter of 2026.

1 May 2026•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.